Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Sphingosine 1-Phosphate Receptor 3 Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine335/Serine337 phosphorylation of the Sphingosine 1-Phosphate Receptor 3
pS335/pS337-S1P3 (phospho-Sphingosine...
Serine335/Serine337 (S335/S337) is major phosphorylation site of the Sphingosine 1-Phosphate Receptor 3 (S1P3). The pS335/pS337-S1P3 antibody detects phosphorylation in response to agonists. S335/S337 phosphorylation is likely to be...
$ 350.00 *
Details
NEW
Validation of the Sphingosine 1-Phosphate Receptor 3 in transfected HEK293 cells.
S1P3 (non-phospho), Sphingosine 1-Phosphate...
The non-phospho-sphingosin 1-phosphate receptor 3 antibody is directed against the distal end of the carboxyl-terminal tail of human S1P3.
$ 375.00 *
Details

S1P3 receptors on marginal zone B cells restrains their migration from the marginal zone to the follicle.  S1P3 has also been implicated in the generation of pain and itch. S1P3 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine335/serine337 (pS335/pS337-S1P3). This nomenclature refers to the human S1P3 receptor. This phosphorylation motif is highly conserved across species and is identical mice, rats and humans. For more information on S1P3 pharmacology please refer to the IUPHAR database. For further reading refer to:

Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev. 2010 Dec;62(4):579-87. doi: 10.1124/pr.110.003111. PMID: 21079037; PMCID: PMC2993255.

Kihara Y, Maceyka M, Spiegel S, Chun J. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 2014 Aug;171(15):3575-94. doi: 10.1111/bph.12678. Epub 2014 Jul 12. PMID: 24602016; PMCID: PMC4128058.

Blaho V, Chun J, Herr D, Jones D, Jonnalagadda D, Kihara Y. Lysophospholipid (S1P) receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

S1P3 receptors on marginal zone B cells restrains their migration from the marginal zone to the follicle.  S1P3 has also been implicated in the generation of pain and itch. S1P3 receptor... read more »
Close window
Sphingosine 1-Phosphate Receptor 3 Antibodies

S1P3 receptors on marginal zone B cells restrains their migration from the marginal zone to the follicle.  S1P3 has also been implicated in the generation of pain and itch. S1P3 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine335/serine337 (pS335/pS337-S1P3). This nomenclature refers to the human S1P3 receptor. This phosphorylation motif is highly conserved across species and is identical mice, rats and humans. For more information on S1P3 pharmacology please refer to the IUPHAR database. For further reading refer to:

Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev. 2010 Dec;62(4):579-87. doi: 10.1124/pr.110.003111. PMID: 21079037; PMCID: PMC2993255.

Kihara Y, Maceyka M, Spiegel S, Chun J. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 2014 Aug;171(15):3575-94. doi: 10.1111/bph.12678. Epub 2014 Jul 12. PMID: 24602016; PMCID: PMC4128058.

Blaho V, Chun J, Herr D, Jones D, Jonnalagadda D, Kihara Y. Lysophospholipid (S1P) receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

Recently viewed